Optibiotix Health Share Discussion Threads

[christopher logsdon] 20/7/2020 12:36

I've tried the product that improves cholesterol had a blood test after using it for only two months and my cholesterol results had improved considerably

[aldermana] 20/7/2020 12:17

Opti has been a real disappointment. I'm still invested, but down to a token stake now. I've tried all their products and not been wildly impressed with them. I'll keep an eye on it in the hope that the sugar substitute comes through, but I don't see this is a buy. More story than substance IMO.

[manc10] 20/7/2020 12:11

christopher i think you will be defo in the money very exciting times

[christopher logsdon] 20/7/2020 12:04

My mistake it does work

[christopher logsdon] 20/7/2020 12:03

I think you need to remove the T from the link

[christopher logsdon] 20/7/2020 12:02

Manc10 I invested in Opti when the share price really had accelerated away so I got in quite late so I'm 40% out of pocket at the moment I hope in the next couple of years I will be in the money

[manc10] 20/7/2020 10:53

OptiBiotix Health PLC (LON:OPTI) said the first half of 2020 saw all of its divisions make progress towards its goal of being profitable this year.

The functional fibres division reported a profit during this period, the ProBiotix division was profitable in three of the six months, and the consumer health division was profitable in one of the six months, OptioBiotix told investors.

Total invoiced sales of LPLDL and SlimBiome as an ingredient or final product shot up by 398% to £741,504 from £148,818 in the first half of last year.

The life sciences business, which is focused on developing compounds to tackle obesity, heart disease and diabetes, also received £747,500 of investment income in the first half of the year from the disposal of shares in SkinBioTherapeutics.

“There is now a trend showing an acceleration in year-on-year revenue growth as more agreements generate revenues, existing partners grow sales and more retail partners launch products. We anticipate further revenue growth in 2020 as interest in the microbiome and products for health and wellbeing grows,” Stephen O’Hara, the chief executive officer of OptiBiotix said in the trading and commercial update.

"Whilst uncertainty within the global economic environment will create challenges we believe our strategy of working with multiple partners, across different application areas and geographies within the healthcare sector, will limit the risk related to any individual deal, product, or geography," he added.

[manc10] 20/7/2020 09:44

opti going well 400% increase in revenue from h1 400% kreature lad you must be ill

[kreature] 20/7/2020 09:41

Bulgaria must be doing well....now that tourists are travelling again

[manc10] 20/7/2020 09:37

nobby will be buzzing sng up 350% and senti called it short

[manc10] 20/7/2020 09:33

cant wait for year end 2020 building superbly

[rayrac] 20/7/2020 09:25

Yes, how about a proactive view...kind of put some figures, not percentages, on the table?!

Smoke and mirrors

[kreature] 20/7/2020 09:17

Do people really still buy clothes at Next? Surely it’s easier to buy clothes with your food in Tesco and Asda or M&S?

[kreature] 20/7/2020 09:08

Not sure why the share price seems a bit stagnant considering the RNS ? How bout a proactive interview ?

[manc10] 20/7/2020 08:59

kreature just buy the shares mate senti has gone now